Ilana Schlam, Breast medical oncologist at Dana-Farber Cancer Institute, shared a post on X:
“Breast cancer research highlights from 2025
A non-exhaustive overview of impactful clinical trials and liquid biopsy work presented at ESMO and SABCS.
ADCs, maintenance, MRD, and molecular response continue to shape where the field is headed. Still a lot more to learn.”
More posts featuring Ilana Schlam.
